Nasus Pharma Presents Intranasal Epinephrine Data at ACAAI Annual Scientific Meeting

PUBT · 2d ago
Nasus Pharma Presents Intranasal Epinephrine Data at ACAAI Annual Scientific Meeting
  • Nasus Pharma will present NS002 anaphylaxis treatment data at the ACAAI annual scientific meeting in Phoenix, Nov. 12-16, 2026.
  • An oral presentation on Nov. 14 will cover absorption of the investigational intranasal epinephrine powder in adults with allergic rhinitis.
  • Three poster presentations on Nov. 13-14 will address absorption under nasal congestion, allergic rhinitis absorption and anaphylaxis treatment priorities.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nasus Pharma Ltd. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611100800PRIMZONEFULLFEED9873989) on November 10, 2026, and is solely responsible for the information contained therein.